PUBLICATION

Alkylgold(III) Complexes Undergo Unprecedented Photo-Induced β-Hydride Elimination and Reduction for Targeted Cancer Therapy

Authors
Jiang, J., Cao, B., Chen, Y., Luo, H., Xue, J., Xiong, X., Zou, T.
ID
ZDB-PUB-220301-1
Date
2022
Source
Angewandte Chemie (International ed. in English)   61(16): e202201103 (Journal)
Registered Authors
Keywords
Anti-Cancer Metallodrug, Gold Medicine, Metal Prodrug, Photoactivated Chemotherapy, Thioredoxin Reductase
MeSH Terms
  • Antineoplastic Agents*/pharmacology
  • Antineoplastic Agents*/therapeutic use
  • Cell Line, Tumor
  • Coordination Complexes*/pharmacology
  • Coordination Complexes*/therapeutic use
  • Gold
  • Humans
  • Ligands
  • Neoplasms*/drug therapy
  • Neoplasms*/pathology
  • Thioredoxin-Disulfide Reductase
PubMed
35165986 Full text @ Angew. Chem. Int. Ed. Engl.
Abstract
Spatiotemporally controllable activation of prodrugs within tumors is highly desirable for cancer therapy to minimize toxic side effects. Herein we report that stable alkylgold(III) complexes can undergo unprecedented photo-induced β-hydride elimination, releasing alkyl ligands and forming gold(III)-hydride intermediates that could be quickly converted into bioactive [AuIII -S] adducts; meanwhile, the remaining alkylgold(III) complexes can photo-catalytically reduce [AuIII -S] into more bioactive AuI species. Such photo-reactivities make it possible to functionalize gold complexes on the auxiliary alkyl ligands without attenuating the metal-biomacromolecule interactions. As a result, the gold(III) complexes containing glucose-functionalized alkyl ligands displayed efficient and tumor-selective uptake; notably, after one- or two-photon activation, the complexes exhibited high thioredoxin reductase (TrxR) inhibition, potent cytotoxicity, and strong antiangiogenesis and antitumor activities in vivo.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping